Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

T3 Pharma treats itself to more funding

Boehringer Ingelheim Venture Fund followed an investment last September by contributing to a $26.8m round for the Basel spinout.


Jul 22, 2020

Purdue packs a punch with 22 new spinouts

The total has dipped slightly from 25 year-on-year despite Purdue reporting more disclosures and patents this fiscal year.

Jul 22, 2020

Cerevance captures $65m series B

UPMC Enterprises has contributed to a $20m series B extension for Cerevance, which is commercialising Rockefeller University research.

Jul 22, 2020

Belkin grabs onto $12.3m

Santen Ventures co-led a series B round to bring TAU faculty-founded Belkin Laser's funding total to $16.3m.

Jul 21, 2020

Daily deal net: July 21, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jul 21, 2020

Freeline progresses towards $100m IPO

UCL's gene therapy developer has followed a $120m round co-led by Novo three weeks ago by filing to go public on the Nasdaq Global Select Market.

Jul 21, 2020

Mori reaps $12m series A

MIT and Tufts spinout Mori, which produces food preservatives using silk proteins, welcomed back The Engine for its series A round.

Jul 21, 2020

Quebec looks to annex university TTOs

University of Montreal, Laval University and ETS are to combine their tech transfer operations within a Quebec-wide initiative due to launch next spring.

Jul 21, 2020

Coursera enrols in $130m series F round

Seek Group returned for a series F round that boosted the Stanford faculty-founded adult education provider's valuation to $2.5bn.

Jul 20, 2020

Daily deal net: July 20, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jul 20, 2020

CureVac cuts $176m equity deal with GSK

GlaxoSmithKline is paying $176m for a 10% stake in University of Tübingen's RNA drug developer in connection with a strategic partnership agreement.

Jul 20, 2020

Berkeley Lights beams on to public markets

UC Berkeley-linked cell biology technology developer Berkeley Lights floated in a $178m offering and its shares almost tripled in price on their first day of trading.

Jul 20, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here